Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2021 May Covid-19 ‘Our COVID algorithm is still up-to-date and in use in every Belgian hospital’ Read more
2021 May Covid-19 Vaccinating into skin instead of muscles could mean many more people can be immunized Read more
2021 May Editor's pick Editor’s pick of Sylvia Snauwaert: relevant literature for your daily practice Read more
Top
